Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Norwalk Leslie V
Over the trailing 90 days, Norwalk Leslie V (Director at NEUROCRINE BIOSCIENCES INC) traded $1.3M of stock (net selling $770K) across 3 companies, per 12 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 12 transactions · CIK 1533568
- Net activity
- −$770K ($258K bought · $1.0M sold)
By Company (Trailing 90 Days)
Transactions (12)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-29 | NBIX | Sell | 842 | $0 | Exercise or conversion of derivative security |
| 2026-07-29 | NBIX | Buy | 842 | $117K | Exercise or conversion of derivative security |
| 2026-07-28 | NBIX | Sell | 1.2K | $228K | Open market or private sale |
| 2026-06-24 | ARVN | Buy | 22.7K | $0 | Grant, award or other acquisition |
| 2026-06-24 | ARVN | Buy | 15.5K | $0 | Grant, award or other acquisition |
| 2026-06-04 | NBIX | Sell | 1.2K | $210K | Open market or private sale |
| 2026-05-27 | NBIX | Buy | 2.6K | $0 | Grant, award or other acquisition |
| 2026-05-27 | NBIX | Buy | 1.3K | $0 | Grant, award or other acquisition |
| 2026-05-21 | NBIX | Sell | 1.7K | $0 | Exercise or conversion of derivative security |
| 2026-05-21 | NBIX | Buy | 1.7K | $0 | Exercise or conversion of derivative security |
| 2026-05-14 | CVS | Buy | 1.4K | $141K | Grant, award or other acquisition |
| 2026-05-12 | NBIX | Sell | 3.8K | $591K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Norwalk's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.